Global CSR Program
Takeda’s Global CSR Program funds multi-year projects to build climate-resilient healthcare, train health workers, and develop health tech innovations for vulnerable communities worldwide.
Funder: Takeda Pharmaceuticals
Due Dates (Anticipated): October 2026
Funding Amounts: Typical awards: JPY 400 million–1.1 billion (approx. $2.5M–$7M USD) per project over 4–10 years; average award: JPY 815 million for 4.8 years.
Summary: Supports long-term projects that build climate-resilient healthcare systems, train health workforces, and foster health technology innovation for vulnerable communities worldwide.
Key Information: Forecasted date—RFP not yet open; only nonprofits and equivalent organizations eligible as lead applicants.
Description
Takeda Pharmaceuticals' Global CSR Program aims to strengthen healthcare systems in vulnerable communities facing the impacts of climate change. The program funds large-scale, multi-year projects that address climate-resilient health infrastructure, health workforce preparedness, and health technology innovation. Projects should enhance healthcare delivery, train professionals to manage climate-related health risks, and develop scalable technology solutions to improve service efficiency and reach. The program emphasizes equity, sustainability, and local ownership, with a strong preference for initiatives benefitting low-resource and marginalized populations.
